AXNX

Axonex AI Group Limited

Healthcare · USD

Set alert

Price alert · AXNX

All alert types
1.06 USD +0.03 +2.91%
As of Oct 30, 2026 Extended hours 1.00 -5.66%
Bid
1.03 × 4
Ask
1.06 × 1
1.00 Day range 1.10
0.76 52-week range 52.50
YTD
-64.67%
1 year
-97.98%
Open
1.07
Prev close
1.03
Mkt cap
6.74M
Vol
101.33K
Avg vol
2.01M
EPS
-10.38
P/E
0.00
Div yield
0.00%
More statistics
Low
1.00
High
1.10
Forward P/E
0.00
Beta
0.83
Short ratio
7.14
Inst. own
87.22%
Dividend
0.00
Ex-div date
Earnings
Nov 7, 2024
50-d avg
0.00
200-d avg
0.00
1y target
0.00

5D chart

Chart tools
Interval
AXNX five-day price chart0.680.810.951.081.21Oct 22Oct 23Oct 26Oct 27Oct 28

Financial health

Altman Z-Score

-0.88 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 1

Valuation

P/E -5.1×
FY 2022: 364×FY 2023: 114×FY 2024: 119×FY 2025: -81.6×FY 2026: -5.1×
FY 2022 5y median 114× FY 2026
P/S 22.9×
FY 2022: 44.1×FY 2023: 35.0×FY 2024: 21.3×FY 2025: 36.5×FY 2026: 22.9×
FY 2022 5y median 35.0× FY 2026
P/B 16.0×
FY 2022: 674×FY 2023: 229×FY 2024: 78.1×FY 2025: 20.6×FY 2026: 16.0×
FY 2022 5y median 78.1× FY 2026
P/FCF -49.2×
FY 2022: -504×FY 2023: 1022×FY 2024: 125×FY 2025: -36.5×FY 2026: -49.2×
FY 2022 5y median -36.5× FY 2026
EV/EBITDA -5.3×
FY 2022: 295×FY 2023: 754×FY 2024: 99.7×FY 2025: -75.4×FY 2026: -5.3×
FY 2022 5y median 99.7× FY 2026
EV/Sales 22.9×
FY 2022: 44.1×FY 2023: 34.9×FY 2024: 21.3×FY 2025: 35.5×FY 2026: 22.9×
FY 2022 5y median 34.9× FY 2026
FCF Yield -2.0%
FY 2022: -0.2%FY 2023: 0.1%FY 2024: 0.8%FY 2025: -2.7%FY 2026: -2.0%
FY 2022 5y median -0.2% FY 2026

Profitability

Gross Margin 0.0%
FY 2022: 29.2%FY 2023: 47.3%FY 2024: 35.6%FY 2025: 22.2%FY 2026: 0.0%
FY 2022 5y median 29.2% FY 2026
Operating Margin -444.7%
FY 2022: 12.4%FY 2023: 4.4%FY 2024: 20.3%FY 2025: -49.8%FY 2026: -444.7%
FY 2022 5y median 4.4% FY 2026
Net Margin -450.3%
FY 2022: 12.1%FY 2023: 30.7%FY 2024: 17.9%FY 2025: -44.7%FY 2026: -450.3%
FY 2022 5y median 12.1% FY 2026
ROE -315.5%
FY 2022: 185.0%FY 2023: 200.3%FY 2024: 65.4%FY 2025: -25.2%FY 2026: -315.5%
FY 2022 5y median 65.4% FY 2026
ROIC -234.5%
FY 2022: 183.5%FY 2023: 24.9%FY 2024: 61.4%FY 2025: -20.6%FY 2026: -234.5%
FY 2022 5y median 24.9% FY 2026
ROA -192.8%
FY 2022: 61.6%FY 2023: 85.5%FY 2024: 37.1%FY 2025: -19.3%FY 2026: -192.8%
FY 2022 5y median 37.1% FY 2026

Growth (YoY)

Revenue -91.0%
FY 2022: 0.0%FY 2023: 26.2%FY 2024: 63.9%FY 2025: -25.5%FY 2026: -91.0%
FY 2022 FY 2026
Operating Income 19.8%
FY 2022: 0.0%FY 2023: -55.1%FY 2024: 654.8%FY 2025: -282.7%FY 2026: 19.8%
FY 2022 FY 2026
EPS (diluted) 17.4%
FY 2022: 0.0%FY 2023: 218.6%FY 2024: -4.4%FY 2025: -286.6%FY 2026: 17.4%
FY 2022 FY 2026
Free Cash Flow 95.8%
FY 2022: 0.0%FY 2023: 149.3%FY 2024: 717.6%FY 2025: -536.5%FY 2026: 95.8%
FY 2022 FY 2026

Financial Health

Current Ratio 1.8×
FY 2022: 1.5×FY 2023: 1.7×FY 2024: 2.3×FY 2025: 9.6×FY 2026: 1.8×
FY 2022 5y median 1.8× FY 2026
Quick Ratio 1.8×
FY 2022: 1.5×FY 2023: 1.7×FY 2024: 2.3×FY 2025: 9.6×FY 2026: 1.8×
FY 2022 5y median 1.8× FY 2026
Debt / Equity 0.3×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.2×FY 2026: 0.3×
FY 2022 5y median 0.0× FY 2026
Net Debt / EBITDA -0.0×
FY 2022: -0.3×FY 2023: -2.4×FY 2024: -0.3×FY 2025: 2.1×FY 2026: -0.0×
FY 2022 5y median -0.3× FY 2026
Interest Coverage -347×
FY 2022: 755×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -47.5×FY 2026: -347×
FY 2022 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2022: 0.0%FY 2023: 0.6%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2022 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2022: 0.0%FY 2023: 66.9%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2022 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-03-31